Thus, the suppressed Foxo3 expression in the presence of TGF-β may hint at an environment conducive to the progression or exacerbation of lung fibrosis, underscoring the need to further explore the molecular mechanisms and potential therapeutic implications of this interaction. Here, FOXO3 is linked to pulmonary fibrosis.